No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Biomarkers, Tumor / metabolism*
-
Dihydrouracil Dehydrogenase (NADP) / metabolism
-
Equilibrative Nucleoside Transporter 1 / metabolism
-
Humans
-
Osteonectin / metabolism
-
Outcome Assessment, Health Care
-
Pancreatic Neoplasms / diagnosis
-
Pancreatic Neoplasms / drug therapy*
-
Pancreatic Neoplasms / metabolism*
-
Prognosis
Substances
-
Biomarkers, Tumor
-
Equilibrative Nucleoside Transporter 1
-
Osteonectin
-
SLC29A1 protein, human
-
SPARC protein, human
-
Dihydrouracil Dehydrogenase (NADP)